Pyk2 binding proteins
CA 2362943 A1 · Owner: Andreev, Julian · Inventors: Schlessinger, Joseph; Andreev, Julian
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The present invention relates to novel Pyk2 binding proteins Pap alpha and Pap beta, nucleotide sequences encoding the novel Pyk2 binding proteins as well , as various products and methods useful for the diagnosis and treatment of various Pyk2 binding protein-related and protein kinase-related diseases and conditions. Through the use of a bioinformatics strategy two mammalian , members of the Pyk2 binding protein family have been identified and their protein structure predicted.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed February 18, 2000. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended February 18, 2020.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by February 18, 2022.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.